These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 9580815
1. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature. Gupta AK, Lynde CW, Lauzon GJ, Mehlmauer MA, Braddock SW, Miller CA, Del Rosso JQ, Shear NH. Br J Dermatol; 1998 Mar; 138(3):529-32. PubMed ID: 9580815 [Abstract] [Full Text] [Related]
2. Terbinafine induced pityriasis rosea-like eruption. George A, Bhatia A, Kanish B, Williams A. Indian J Pharmacol; 2015 Mar; 47(6):680-1. PubMed ID: 26729964 [Abstract] [Full Text] [Related]
3. Erythema multiforme during cytomegalovirus infection and oral therapy with terbinafine: a virus-drug interaction. Carducci M, Latini A, Acierno F, Amantea A, Capitanio B, Santucci B. J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):201-3. PubMed ID: 15009306 [Abstract] [Full Text] [Related]
4. Psoriatic Erythroderma Caused by Terbinafine: A Possible Pathogenetic Role for IL-23. Oda T, Sawada Y, Yamaguchi T, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Okada E, Nakamura M. J Investig Allergol Clin Immunol; 2017 Mar; 27(1):63-64. PubMed ID: 28211348 [No Abstract] [Full Text] [Related]
16. Rowell's syndrome induced by terbinafine. Murad A, Shudell E, Mulligan N. BMJ Case Rep; 2015 May 28; 2015():. PubMed ID: 26021384 [Abstract] [Full Text] [Related]
17. Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine. Carstens J, Wendelboe P, Søgaard H, Thestrup-Pedersen K. Acta Derm Venereol; 1994 Sep 28; 74(5):391-2. PubMed ID: 7817681 [Abstract] [Full Text] [Related]